Adiponectin as an anti-inflammatory factor - PubMed (original) (raw)

Review

Adiponectin as an anti-inflammatory factor

Noriyuki Ouchi et al. Clin Chim Acta. 2007.

Abstract

Obesity is characterized by low-grade systemic inflammation. Adiponectin is an adipose tissue-derived hormone, which is downregulated in obesity. Adiponectin displays protective actions on the development of various obesity-linked diseases. Several clinical studies demonstrate the inverse relationship between plasma adiponectin levels and several inflammatory markers including C-reactive protein. Adiponectin attenuates inflammatory responses to multiple stimuli by modulating signaling pathways in a variety of cell types. The anti-inflammatory properties of adiponectin may be a major component of its beneficial effects on cardiovascular and metabolic disorders including atherosclerosis and insulin resistance. In this review, we focus on the role of adiponectin in regulation of inflammatory response and discuss its potential as an anti-inflammatory marker.

PubMed Disclaimer

Figures

Figure

Adiponectin-mediated regulation of inflammatory responses in different cell types. Adiponectin negatively regulates CRP and TNF-α expression in adipose tissue, whereas adiponectin expression is inhibited by TNF-α and IL-6. Adiponectin inhibits IL-8, VCAM-1 and ROS production in endothelial cells through cAMP-PKA-dependent signaling. Adiponectin also stimulates AMPK activation in endothelial cells, leading to activation of eNOS. Adiponectin suppresses TNF-α production in cardiac cells through its ability to stimulate the COX-2-PGE2 pathway. In macrophages, adiponectin attenuates TNF-α and IL-6 production through its ability to suppress NF-κB activation, and enhances IL-10 expression resulting in increase in TIMP-1 production. Adiponectin inhibits foam cell formation by reducing SR-A expression.

References

1. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112:1785–8. - PMC - PubMed
1. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003;14:561–566. - PubMed
1. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939–949. - PubMed
1. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271:10697–10703. - PubMed
1. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) Biochem Biophys Res Commun. 1996;221:286–289. - PubMed

Adiponectin as an anti-inflammatory factor - PubMed (original) (raw)